Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2013

Open Access 01-12-2013 | Original investigation

Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking

Authors: Matilde E Otero-Losada, Santiago Mc Loughlin, Gastón Rodríguez-Granillo, Angélica Müller, Graciela Ottaviano, Marisa Moriondo, Juan C Cutrin, José Milei

Published in: Cardiovascular Diabetology | Issue 1/2013

Login to get access

Abstract

Background

Atherosclerosis is a major health burden. Metabolic disorders had been associated with large consumption of soft drinks. The rising incidence of atherosclerosis and metabolic alterations warrants the study of long-term soft drink consumption’ effects on metabolism and atherosclerosis in genetic deficiency of apolipoprotein E which typically develops spontaneous atherosclerosis and metabolic alterations.

Methods

ApoE-/- mice were randomized in 3 groups accordingly with free access to: water (W), regular cola (C) or light cola (L). After 8 weeks, 50% of the animals in each group were euthanized (Treatment: W8, C8, L8). The remaining mice (all groups) drank water for 8 weeks and were euthanized (Washout: W16, C16, L16). Body weight and food and drink consumption were periodically measured. Blood was collected (biochemistry). At autopsy, transverse aortic sinus sections were serially cut and stained (histomorphometry); livers and kidneys were processed (microscopy). MANOVA (identification of variance factors) was followed by ANOVA and LSD tests (within-factor differences between levels). Conventionally a p< 0.05 was considered significant.

Results

Treatment increased drinking volumes (vs W8: 4 fold C8, p<0.0001; +47% L8, p<0.02). Only C reduced eating amounts (–54%, p<0.05 vs W8). I). Compared with W8: C8 developed hyperglycemia (+43%, p<0.03) and increased non-HDL cholesterol (+54%, p<0.05); L8 showed decreased glycemia (–15%, p<0.05 vs W8) and increased creatinine (2.5 fold, p<0.04), urea (+74, p<0.03) and aspartate-aminotransferase (2.8 fold, p<0.05). Hypercreatininemia was observed in L16 (2.7 fold vs W16, p<0.05). Hypertriglyceridemia (+91%, p<0.008) and hyperuremia (+68%, p<0.03) developed over time of study (age). II). Treatment caused plaque area increase (vs W8: 28% C8, p<0.02 and 50% L8, p<0.01; vs W16: 43% C16, p<0.05 and 68% L16, p<0.02) and stenosis (vs W8: 38% C8, p<0.04 and 57% L8, p<0.01; vs W16: 71% C16, p<0.01 and 46% L16, p<0.04). Age also caused plaque area increase (56%, p<0.04). Treatment- and age-effects on plaque enlargement were additive.

Conclusion

Cola beverages caused atherosclerotic lesions’ enlargement with metabolic (C) or non metabolic disturbances (L). ApoE-/- mice were particularly sensitive to L treatment. These findings may likely relate to caramel colorant and non-nutritive sweeteners in cola drinks and have potential implications in particularly sensitive individuals.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vasquez EC, Peotta VA, Gava AL, Pereira TM, Meyrelles SS: Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci. 2012, 19: 22.CrossRefPubMedPubMedCentral Vasquez EC, Peotta VA, Gava AL, Pereira TM, Meyrelles SS: Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse. J Biomed Sci. 2012, 19: 22.CrossRefPubMedPubMedCentral
2.
go back to reference Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan RS: Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007, 116: 480-488.CrossRefPubMed Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D’Agostino RB, Gaziano JM, Vasan RS: Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007, 116: 480-488.CrossRefPubMed
4.
go back to reference Milei J, Otero Losada M, Gómez Llambí H, Grana DR, Suárez D, Azzato F, Ambrosio G: Chronic cola drinking induces metabolic and cardiac alterations in rats. World J Cardiol. 2011, 3: 111-116.CrossRefPubMedPubMedCentral Milei J, Otero Losada M, Gómez Llambí H, Grana DR, Suárez D, Azzato F, Ambrosio G: Chronic cola drinking induces metabolic and cardiac alterations in rats. World J Cardiol. 2011, 3: 111-116.CrossRefPubMedPubMedCentral
5.
go back to reference Otero-Losada ME, Grana DR, Müller A, Ottaviano G, Ambrosio G, Milei J: Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat. Int J Cardiol. 2011, 146: 106-109.CrossRefPubMed Otero-Losada ME, Grana DR, Müller A, Ottaviano G, Ambrosio G, Milei J: Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat. Int J Cardiol. 2011, 146: 106-109.CrossRefPubMed
6.
go back to reference Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992, 258: 468-471.CrossRefPubMed Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992, 258: 468-471.CrossRefPubMed
7.
go back to reference Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8: e1000412.CrossRefPubMedPubMedCentral Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8: e1000412.CrossRefPubMedPubMedCentral
8.
go back to reference Bea F, Blessing E, Bennett BJ, Kuo CC, Campbell LA, Kreuzer J, Rosenfeld ME: Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res. 2003, 60: 198-20.CrossRefPubMed Bea F, Blessing E, Bennett BJ, Kuo CC, Campbell LA, Kreuzer J, Rosenfeld ME: Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res. 2003, 60: 198-20.CrossRefPubMed
9.
go back to reference Brown RJ, Walter M, Rother KI: Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009, 32: 2184-2186.CrossRefPubMedPubMedCentral Brown RJ, Walter M, Rother KI: Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care. 2009, 32: 2184-2186.CrossRefPubMedPubMedCentral
12.
go back to reference Humphries P, Pretorius E, Naudé H: Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr. 2008, 62: 451-462.CrossRefPubMed Humphries P, Pretorius E, Naudé H: Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr. 2008, 62: 451-462.CrossRefPubMed
13.
go back to reference Calbet JA, MacLean DA: Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J Nutr. 2002, 132: 2174-2182.PubMed Calbet JA, MacLean DA: Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J Nutr. 2002, 132: 2174-2182.PubMed
14.
go back to reference Balarini CM, Oliveira MZ, Pereira TM, Silva NF, Vasquez EC, Meyrelles SS, Gava AL: Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis. 2011, 10: 220.CrossRefPubMedPubMedCentral Balarini CM, Oliveira MZ, Pereira TM, Silva NF, Vasquez EC, Meyrelles SS, Gava AL: Hypercholesterolemia promotes early renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis. 2011, 10: 220.CrossRefPubMedPubMedCentral
15.
go back to reference D’Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, Pettoello-Mantovani M, Campanozzi A, Raia V, Pessin JE, Brownlee M, Giardino I: Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest. 2010, 120: 203-213.CrossRefPubMed D’Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, Pettoello-Mantovani M, Campanozzi A, Raia V, Pessin JE, Brownlee M, Giardino I: Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest. 2010, 120: 203-213.CrossRefPubMed
16.
go back to reference Su L, Zhang H, Zhao J, Zhang S, Zhang Y, Zhao B, Miao J: Safrole-2′,3′-oxide induces atherosclerotic plaque vulnerability in apolipoprotein E-knockout mice. Toxicol Lett. 2013, 217: 129-136.CrossRefPubMed Su L, Zhang H, Zhao J, Zhang S, Zhang Y, Zhao B, Miao J: Safrole-2,3-oxide induces atherosclerotic plaque vulnerability in apolipoprotein E-knockout mice. Toxicol Lett. 2013, 217: 129-136.CrossRefPubMed
17.
go back to reference Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC: Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis. 2011, 10: 211.CrossRefPubMedPubMedCentral Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC: Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis. 2011, 10: 211.CrossRefPubMedPubMedCentral
18.
go back to reference Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS: Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis. 2010, 9: 87.CrossRefPubMedPubMedCentral Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS: Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis. 2010, 9: 87.CrossRefPubMedPubMedCentral
19.
go back to reference Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS: Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010, 17: 511-531.CrossRefPubMedPubMedCentral Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS: Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci. 2010, 17: 511-531.CrossRefPubMedPubMedCentral
20.
go back to reference Thomas CM, Smart EJ: Gender as a regulator of atherosclerosis in murine models. Curr Drug Targets. 2007, 8: 1172-1180.CrossRefPubMed Thomas CM, Smart EJ: Gender as a regulator of atherosclerosis in murine models. Curr Drug Targets. 2007, 8: 1172-1180.CrossRefPubMed
21.
go back to reference Freudenberger T, Oppermann M, Heim HK, Mayer P, Kojda G, Schrör K, Fischer JW: Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol. 2010, 105: 479-486.CrossRefPubMed Freudenberger T, Oppermann M, Heim HK, Mayer P, Kojda G, Schrör K, Fischer JW: Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol. 2010, 105: 479-486.CrossRefPubMed
22.
go back to reference Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK: Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999, 145: 301-308.CrossRefPubMed Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK: Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis. 1999, 145: 301-308.CrossRefPubMed
23.
go back to reference Li J, Wang Q, Chai W, Chen MH, Liu Z, Shi W: Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. Cardiovasc Diabetol. 2011, 10: 117.CrossRefPubMedPubMedCentral Li J, Wang Q, Chai W, Chen MH, Liu Z, Shi W: Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. Cardiovasc Diabetol. 2011, 10: 117.CrossRefPubMedPubMedCentral
24.
go back to reference Tiyerili V, Becher UM, Aksoy A, Lütjohann D, Wassmann S, Nickenig G, Mueller CF: AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARgamma. Cardiovasc Diabetol. 2013, 12: 30.CrossRefPubMedPubMedCentral Tiyerili V, Becher UM, Aksoy A, Lütjohann D, Wassmann S, Nickenig G, Mueller CF: AT1-receptor-deficiency induced atheroprotection in diabetic mice is partially mediated via PPARgamma. Cardiovasc Diabetol. 2013, 12: 30.CrossRefPubMedPubMedCentral
25.
go back to reference Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation. 2004, 110: 3062-3067.CrossRefPubMed Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G: Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation. 2004, 110: 3062-3067.CrossRefPubMed
26.
go back to reference Pasqui AL, Bova G, Maffei S, Auteri A: Immune factors in atherosclerosis. Ann Ital Med Int. 2005, 20: 81-89.PubMed Pasqui AL, Bova G, Maffei S, Auteri A: Immune factors in atherosclerosis. Ann Ital Med Int. 2005, 20: 81-89.PubMed
27.
go back to reference Buzello M, Törnig J, Faulhaber J, Ehmke H, Ritz E, Amann K: The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003, 14: 311-316.CrossRefPubMed Buzello M, Törnig J, Faulhaber J, Ehmke H, Ritz E, Amann K: The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003, 14: 311-316.CrossRefPubMed
28.
go back to reference Creppy EE, Baudrimont I, Anne-Marie W: How aspartame prevents the toxicity of ochratoxin A. J Toxicol Sci. 1998, 23: 165-172.CrossRefPubMed Creppy EE, Baudrimont I, Anne-Marie W: How aspartame prevents the toxicity of ochratoxin A. J Toxicol Sci. 1998, 23: 165-172.CrossRefPubMed
29.
go back to reference Yu J, Deng M, Zhao J, Huang L: Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2010, 391: 261-266.CrossRefPubMed Yu J, Deng M, Zhao J, Huang L: Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2010, 391: 261-266.CrossRefPubMed
30.
go back to reference Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B, Descamps-Latscha B, Drüeke TB, Massy ZA: The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int. 2005, 67: 2288-2294.CrossRefPubMed Ivanovski O, Szumilak D, Nguyen-Khoa T, Ruellan N, Phan O, Lacour B, Descamps-Latscha B, Drüeke TB, Massy ZA: The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int. 2005, 67: 2288-2294.CrossRefPubMed
31.
go back to reference Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005, 16: 109-116.CrossRefPubMed Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB, Muntzel MS: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005, 16: 109-116.CrossRefPubMed
Metadata
Title
Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking
Authors
Matilde E Otero-Losada
Santiago Mc Loughlin
Gastón Rodríguez-Granillo
Angélica Müller
Graciela Ottaviano
Marisa Moriondo
Juan C Cutrin
José Milei
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2013
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-12-57

Other articles of this Issue 1/2013

Cardiovascular Diabetology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine